This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.

Provides readers with recent progress in basic and clinical research of cancer immunotherapy Covers hot topics in cancer immunotherapy, such as cancer vaccines, monoclonal antibodies and adoptive cellular therapy Written by experts in this fields Includes supplementary material: sn.pub/extras

Autorentext
Dr. Shuren Zhang is a professor and the director of Department of Immunology, Cancer Institute & HospitalChinese Academy of Medical Sciences & Peking Union Medical College. He is the vice chairman of the society of Cancer Biotherapy of Chinese Anti-Cancer Association. His research focuses on tumor immunology and cancer immunotherapy, and he has published more than 60 research articles in this field.

Inhalt
Antibody therapies in cancer.- Biological Response Modifier in Cancer Immunotherapy.- Progress and Development of Therapeutic Cancer Vaccines.- Adoptive Cellular Therapy (ACT) for Cancer Treatment.- Oncolytic Immunotherapy for Treatment of Cancer.